Manhattan Associates revenue and financials
In the fiscal year ended December 2025, Manhattan Associates reported revenue of $1.08B (+3.75% year over year). Net income was $219.95M, a net margin of 20.3%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +3.75%
- 2025 vs 2024
- Net income growth
- +0.73%
- 2025 vs 2024
- Net margin
- 20.3%
- 2024: 20.9%
How Manhattan Associates is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 13.0% a year on average over the last 5 years
Compound annual growth rate: from $586.37M in 2020 to $1.08B in 2025.
Revenue has grown for 5 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 19.9% to 25.9%
Operating income over revenue, 2022 → 2025: 6.0 percentage points.
Profits turn into cash: free cash flow equal to 147% of net income
Totals for fiscal years 2023–2025: free cash flow $901.83M, net income $614.88M.
Shares outstanding down 5.1% in 5 years
Average diluted shares, 2020 → 2025: with fewer shares, each one represents a larger stake in the company.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,081 | 1,042 | 929 | 767 | 664 | 586 | 618 | 559 | 595 | 605 |
| Cost of revenue | 472 | 471 | 431 | 358 | 298 | 270 | 285 | 241 | 246 | 250 |
| Gross profit | 609 | 571 | 498 | 409 | 366 | 316 | 333 | 318 | 349 | 355 |
| Selling, general and administrative | 175 | 166 | 156 | 138 | 126 | 109 | 121 | 104 | 93.5 | 96.5 |
| Research and development | 145 | 138 | 127 | 112 | 97.6 | 84.3 | 87.6 | 71.9 | 57.7 | 54.7 |
| Operating income | 280 | 262 | 210 | 153 | 134 | 114 | 116 | 134 | 186 | 194 |
| EBIT | 283 | 262 | 210 | 153 | 134 | 114 | 116 | 134 | 189 | 194 |
| EBITDA | 289 | 268 | 216 | 159 | 142 | 123 | 124 | 143 | 198 | 203 |
| Pre-tax income | 286 | 267 | 214 | 158 | 134 | 114 | 116 | 136 | 185 | 196 |
| Income tax | 65.9 | 48.5 | 37.1 | 29.2 | 23.6 | 26.5 | 30.3 | 31.5 | 68.4 | 71.9 |
| Net income | 220 | 218 | 177 | 129 | 110 | 87.2 | 85.8 | 105 | 116 | 124 |
| Net income to common shareholders | 220 | 218 | 177 | 129 | 110 | 87.2 | 85.8 | 105 | 116 | 124 |
| Basic EPS | 3.64 | 3.56 | 2.86 | 2.05 | 1.74 | 1.37 | 1.33 | 1.58 | 1.68 | 1.73 |
| Diluted EPS | 3.60 | 3.51 | 2.82 | 2.03 | 1.72 | 1.36 | 1.32 | 1.58 | 1.68 | 1.72 |
| Average shares (basic) | 60.5 | 61.3 | 61.8 | 62.8 | 63.4 | 63.5 | 64.4 | 66.2 | 69.2 | 71.7 |
| Average shares (diluted) | 61.1 | 62.2 | 62.6 | 63.4 | 64.3 | 64.3 | 65.1 | 66.4 | 69.4 | 72.1 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 306 | 298 | 282 | 270 | 276 | 272 | 263 | 256 | 267 | 265 | 255 | 238 |
| Cost of revenue | 132 | 129 | 127 | 122 | 120 | 116 | 115 | 113 | 119 | 120 | 119 | 107 |
| Gross profit | 174 | 168 | 156 | 149 | 156 | 156 | 148 | 143 | 148 | 145 | 135 | 132 |
| Selling, general and administrative | 56.0 | 57.4 | 51.5 | 41.6 | 42.1 | 46.0 | 45.3 | 47.5 | 36.9 | 40.3 | 41.1 | 39.8 |
| Research and development | 35.5 | 34.8 | 37.3 | 38.5 | 36.4 | 34.9 | 35.3 | 33.0 | 34.3 | 35.3 | 35.0 | 31.3 |
| Operating income | 81.0 | 74.5 | 64.9 | 67.0 | 75.8 | 73.8 | 66.1 | 60.7 | 75.1 | 68.2 | 57.6 | 58.9 |
| EBIT | 81.0 | 74.5 | 64.9 | 67.0 | 75.8 | 73.8 | 66.1 | 60.7 | 75.1 | 68.2 | 57.6 | 58.9 |
| EBITDA | 82.7 | 76.1 | 66.8 | 68.5 | 77.5 | 75.4 | 67.6 | 62.3 | 76.8 | 69.7 | 59.1 | 60.4 |
| Pre-tax income | 82.9 | 67.2 | 69.3 | 68.5 | 78.4 | 74.5 | 64.5 | 62.7 | 76.4 | 69.1 | 58.6 | 59.7 |
| Income tax | 21.5 | 16.9 | 20.0 | 16.5 | 19.8 | 17.7 | 11.9 | 14.7 | 12.6 | 16.3 | 4.8 | 11.0 |
| Net income | 61.3 | 50.4 | 49.3 | 52.0 | 58.6 | 56.8 | 52.6 | 48.0 | 63.8 | 52.8 | 53.8 | 48.7 |
| Net income to common shareholders | 61.3 | 50.4 | 49.3 | 52.0 | 58.6 | 56.8 | 52.6 | 48.0 | 63.8 | 52.8 | 53.8 | 48.7 |
| Basic EPS | 1.05 | 0.86 | 0.83 | 0.87 | 0.97 | 0.94 | 0.86 | 0.79 | 1.04 | 0.86 | 0.87 | 0.79 |
| Diluted EPS | 1.04 | 0.85 | 0.82 | 0.85 | 0.96 | 0.93 | 0.85 | 0.77 | 1.03 | 0.85 | 0.86 | 0.77 |
| Average shares (basic) | 58.2 | 58.8 | 59.7 | 60.0 | 60.4 | 60.6 | 60.9 | 61.0 | 61.2 | 61.4 | 61.6 | 61.6 |
| Average shares (diluted) | 58.7 | 59.0 | 60.0 | 60.6 | 61.0 | 61.1 | 61.5 | 62.0 | 61.9 | 62.1 | 62.5 | 62.6 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 839 | 758 | 673 | 570 | 540 | 465 | 372 | 307 | 315 | 297 |
| Current assets | 583 | 503 | 479 | 415 | 408 | 334 | 232 | 215 | 228 | 207 |
| Cash and equivalents | 329 | 266 | 271 | 225 | 264 | 205 | 111 | 99.1 | 126 | 95.6 |
| Short-term investments | — | — | — | — | — | — | — | 1.4 | — | — |
| Receivables | 221 | 211 | 183 | 167 | 127 | 111 | 102 | 101 | 92.2 | 100 |
| Net property, plant and equipment | 73.6 | 61.9 | 33.4 | 30.6 | 41.2 | 49.4 | 58.6 | 14.3 | 15.5 | 17.4 |
| Goodwill | 62.2 | 62.2 | 62.2 | 62.2 | 62.2 | 62.3 | 62.2 | 62.2 | 62.2 | 62.2 |
| Current liabilities | 456 | 400 | 366 | 316 | 249 | 197 | 182 | 145 | 124 | 118 |
| Accounts payable | 22.2 | 26.6 | 24.5 | 25.7 | 19.6 | 17.8 | 20.6 | 18.2 | 14.0 | 12.1 |
| Total debt | 61.1 | 47.8 | 17.7 | 14.1 | 23.2 | 27.8 | 32.4 | — | — | — |
| Total liabilities | 525 | 458 | 395 | 343 | 289 | 247 | 230 | 160 | 140 | 128 |
| Total equity (incl. minority) | 315 | 299 | 278 | 227 | 251 | 219 | 142 | 147 | 175 | 169 |
| Retained earnings | 345 | 329 | 305 | 254 | 270 | 237 | 159 | 163 | 186 | 185 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 751 | 699 | 741 | 839 | 769 | 745 | 708 | 758 | 698 | 665 | 675 | 673 |
| Current assets | 513 | 467 | 516 | 583 | 526 | 483 | 455 | 503 | 452 | 426 | 445 | 479 |
| Cash and equivalents | 199 | 186 | 226 | 329 | 264 | 231 | 206 | 266 | 215 | 203 | 208 | 271 |
| Receivables | 268 | 219 | 227 | 221 | 220 | 210 | 211 | 211 | 200 | 191 | 206 | 183 |
| Net property, plant and equipment | 68.3 | 70.8 | 72.7 | 73.6 | 65.8 | 63.3 | 61.9 | 61.9 | 62.9 | 64.6 | 64.7 | 33.4 |
| Goodwill | 62.2 | 62.2 | 62.2 | 62.2 | 62.2 | 62.2 | 62.2 | 62.2 | 62.2 | 62.2 | 62.2 | 62.2 |
| Current liabilities | 480 | 475 | 467 | 456 | 400 | 407 | 405 | 400 | 362 | 363 | 372 | 366 |
| Accounts payable | 22.1 | 30.7 | 22.4 | 22.2 | 21.4 | 23.9 | 24.2 | 26.6 | 23.2 | 25.6 | 26.4 | 24.5 |
| Total debt | 51.7 | 53.9 | 55.7 | 61.1 | 47.7 | 48.6 | 47.0 | 47.8 | 50.0 | 50.8 | 51.8 | — |
| Total liabilities | 550 | 541 | 535 | 525 | 460 | 466 | 463 | 458 | 420 | 425 | 435 | 395 |
| Total equity (incl. minority) | 201 | 158 | 205 | 315 | 309 | 279 | 245 | 299 | 278 | 241 | 240 | 278 |
| Retained earnings | 239 | 194 | 241 | 345 | 339 | 304 | 274 | 329 | 303 | 268 | 267 | 305 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 389 | 295 | 246 | 180 | 185 | 141 | 147 | 137 | 164 | 139 |
| Depreciation and amortization | 6.3 | 6.3 | 5.8 | 6.7 | 7.9 | 8.9 | 8.0 | 8.6 | 9.1 | 9.1 |
| Capital expenditure | -15.5 | -8.7 | -4.7 | -6.6 | -4.0 | -2.7 | -15.2 | -7.3 | -6.2 | -6.8 |
| Investing cash flow | -15.5 | -8.7 | -4.7 | -6.6 | -4.0 | -2.7 | -13.8 | -9.8 | -5.8 | 3.4 |
| Financing cash flow | -315 | -286 | -196 | -204 | -120 | -43.6 | -121 | -149 | -132 | -163 |
| Share repurchases | -315 | -286 | -196 | -204 | -120 | -43.6 | -121 | -149 | -132 | -168 |
| Effect of exchange rates | 3.7 | -4.5 | -0.2 | -6.8 | -1.7 | -0.6 | -0.1 | -4.6 | 3.3 | -2.8 |
| Net change in cash | 62.5 | -4.5 | 45.3 | -38.2 | 59.0 | 94.0 | 11.6 | -26.4 | 29.9 | -22.8 |
| Free cash flow | 374 | 286 | 241 | 173 | 181 | — | — | — | — | — |
| Levered free cash flow | 312 | 260 | 236 | 176 | 168 | 118 | 127 | 114 | 152 | 127 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 68.6 | 90.7 | 84.0 | 147 | 93.1 | 74.1 | 75.3 | 105 | 62.3 | 73.3 | 54.7 | 88.4 |
| Depreciation and amortization | 1.7 | 1.6 | 1.8 | 1.5 | 1.7 | 1.6 | 1.5 | 1.6 | 1.7 | 1.5 | 1.5 | 1.5 |
| Capital expenditure | -1.0 | -1.0 | -4.1 | -4.7 | -5.9 | -4.0 | -0.9 | -3.1 | -1.0 | -2.2 | -2.3 | -2.0 |
| Investing cash flow | -1.0 | -1.0 | -4.1 | -4.7 | -5.9 | -4.0 | -0.9 | -3.1 | -1.0 | -2.2 | -2.3 | -2.0 |
| Financing cash flow | -50.5 | -127 | -179 | -77.0 | -51.5 | -50.2 | -136 | -45.2 | -51.6 | -75.7 | -114 | -0.3 |
| Share repurchases | -50.5 | -127 | -179 | -77.0 | -51.5 | -50.2 | -136 | -45.2 | -51.6 | -75.7 | -114 | -0.3 |
| Effect of exchange rates | -3.8 | -2.6 | -3.2 | -0.2 | -2.7 | 4.8 | 1.7 | -5.1 | 2.6 | -0.1 | -1.8 | 2.4 |
| Net change in cash | 13.3 | -40.0 | -103 | 65.2 | 33.0 | 24.7 | -60.4 | 51.3 | 12.2 | -4.8 | -63.2 | 88.4 |
| Free cash flow | 67.6 | 89.7 | 79.9 | 142 | 87.2 | 70.1 | 74.4 | 102 | 61.3 | 71.0 | 52.4 | 86.4 |
| Levered free cash flow | 58.1 | 93.0 | 46.1 | 128 | 54.5 | 66.9 | 63.1 | 97.4 | 57.1 | 71.5 | 34.2 | 89.5 |
Financial statements of similar companies
Companies in the group: same industry, similar size
